{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:39:13Z","timestamp":1769024353133,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.amjms.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T17:01:33Z","timestamp":1520269293000},"page":"530-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increased Cystatin C Level in ST-Elevation Myocardial Infarction Predisposes the Prognosis of Angioplasty"],"prefix":"10.1016","volume":"355","author":[{"given":"Guidong","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuewu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2018.03.003_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/CIR.0000000000000336","volume":"133","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2018.03.003_bib2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MCA.0b013e32835e5c67","article-title":"Early routine angioplasty versus selective angioplasty after successful thrombolysis in acute ST-segment elevation myocardial infarction","volume":"24","author":"Geng","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjms.2018.03.003_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cjca.2011.09.011","article-title":"Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE)","volume":"28","author":"Czarnecki","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1540-8183.2010.00581.x","article-title":"Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions","volume":"23","author":"Chong","year":"2010","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2143\/AC.64.4.2041609","article-title":"Clinical efficacy and safety of enoxaparin in unselected Swiss patients undergoing primary or elective percutaneous coronary intervention: analysis of the RIVIERA study","volume":"64","author":"Weber","year":"2009","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.amjms.2018.03.003_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ahj.2015.02.019","article-title":"Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the platelet inhibition and patient outcomes trial","volume":"169","author":"Velders","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjms.2018.03.003_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/eurheartj\/eht530","article-title":"Biomarkers and acute coronary syndromes: an update","volume":"35","author":"Mueller","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.03.003_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacc.2007.11.054","article-title":"N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission","volume":"51","author":"Weber","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib10","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000145166.44942.E0","article-title":"Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome","volume":"110","author":"Jernberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2018.03.003_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1373\/clinchem.2011.171520","article-title":"Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes Study","volume":"58","author":"Akerblom","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.amjms.2018.03.003_bib12","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1016\/j.jcrc.2013.03.004","article-title":"Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction","volume":"28","author":"Akgul","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.amjms.2018.03.003_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clinbiochem.2012.02.012","article-title":"Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome","volume":"45","author":"Ristiniemi","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.amjms.2018.03.003_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1373\/clinchem.2008.119669","article-title":"Invasive versus conservative treatment in unstable coronary syndromes I. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T","volume":"55","author":"Windhausen","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.amjms.2018.03.003_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/clinchem\/48.5.699","article-title":"Cystatin C: an improved estimator of glomerular filtration rate?","volume":"48","author":"Laterza","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.amjms.2018.03.003_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cvr\/cvq138","article-title":"Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation","volume":"87","author":"Xie","year":"2010","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.amjms.2018.03.003_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients","volume":"20","author":"Killip","year":"1967","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2018.03.003_bib19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.amjcard.2012.01.356","article-title":"Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction","volume":"109","author":"Silva","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.03.003_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2012.11.018","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"61","author":"American College of Emergency P, Society for Cardiovascular A, Interventions","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/hrt.2007.119750","article-title":"Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes","volume":"94","author":"Gao","year":"2008","journal-title":"Heart."},{"key":"10.1016\/j.amjms.2018.03.003_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCOUTCOMES.113.000526","article-title":"Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial","volume":"7","author":"Du","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjms.2018.03.003_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjms.2018.03.003_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000064453","article-title":"Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine","volume":"92","author":"Shimizu-Tokiwa","year":"2002","journal-title":"Nephron."},{"key":"10.1016\/j.amjms.2018.03.003_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1253\/circj.CJ-08-0943","article-title":"Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction","volume":"73","author":"Ichimoto","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.amjms.2018.03.003_bib27","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1681\/ASN.2009050546","article-title":"Rapid decline of kidney function increases cardiovascular risk in the elderly","volume":"20","author":"Shlipak","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjms.2018.03.003_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/clc.20672","article-title":"Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome","volume":"32","author":"Ge","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjms.2018.03.003_bib29","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and cardiovascular risk","volume":"55","author":"Taglieri","year":"2009","journal-title":"Clin Chem"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918300879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918300879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:02:56Z","timestamp":1603929776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962918300879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0002962918300879"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.03.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Cystatin C Level in ST-Elevation Myocardial Infarction Predisposes the Prognosis of Angioplasty","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}